|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|
| Non-current assets | |||||||||
| Property, plant and equipment | |||||||||
| Investment property | |||||||||
| Intangible assets | |||||||||
| Investments in joint ventures and associates | |||||||||
| Deferred income tax assets | |||||||||
| Financial assets – derivative financial instruments | |||||||||
| Retirement benefit assets | |||||||||
| Other financial assets | |||||||||
| Income tax assets | |||||||||
| Trade and other receivables | |||||||||
| Total non-current assets | |||||||||
| Current assets | |||||||||
| Intangible assets – product development | |||||||||
| Inventories | |||||||||
| Trade and other receivables | |||||||||
| Financial assets – derivative financial instruments | |||||||||
| Income tax assets | |||||||||
| Cash and cash equivalents (excluding overdrafts) | |||||||||
| Total current assets | |||||||||
| Assets classified as held for sale | |||||||||
| Total assets | |||||||||
| Non-current liabilities | |||||||||
| Financial liabilities – borrowings | |||||||||
| Financial liabilities – derivative financial instruments | |||||||||
| Deferred income tax liabilities | |||||||||
| Retirement benefit obligations | |||||||||
| Provisions for other liabilities and charges | |||||||||
| Other liabilities | |||||||||
| Non-current liabilities | |||||||||
| Current liabilities | |||||||||
| Trade and other liabilities | |||||||||
| Financial liabilities – borrowings | |||||||||
| Financial liabilities – derivative financial instruments | |||||||||
| Income tax liabilities | |||||||||
| Provisions for other liabilities and charges | |||||||||
| Total current liabilities | |||||||||
| Total liabilities | |||||||||
| Net assets | |||||||||
| Equity | |||||||||
| Share capital | |||||||||
| Share premium | |||||||||
| Treasury shares | |||||||||
| Capital redemption reserve | |||||||||
| Fair value reserve | |||||||||
| Translation reserve | |||||||||
| Retained earnings | |||||||||
| Total equity attributable to equity holders of the company | |||||||||
| Non-controlling interest | |||||||||
| Total equity | |||||||||
Loading...
